Related Experiment Video
Updated: Jul 24, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipid Profile and Lipoprotein(a) Testing
Klaus G Parhofer1, Ulrich Laufs
1Internal Medicine IV-Großhadern, LMU Hospital, Munich, Germany; Department of Cardiology, University Hospital of Leipzig, Leipzig, Germany.
Accurate lipid status evaluation is crucial for cardiovascular disease prevention. Lowering LDL cholesterol through lifestyle changes and medication is key to managing dyslipidemias and reducing health risks.
Area of Science:
- Cardiology
- Clinical Lipidology
- Preventive Medicine
Background:
- Dyslipidemias significantly impact cardiovascular disease (CVD) primary and secondary prevention.
- Accurate assessment of patient lipid status is vital for CVD risk stratification and guiding treatment decisions.
Conclusions:
- Cholesterol, triglycerides, HDL-, and LDL-cholesterol measurements guide lipid-lowering therapy.
- The primary objective of lipid management is to reduce LDL cholesterol levels to an appropriate target based on cardiovascular risk.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis I: Introduction

